Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Veerle Vanheusden is active.

Publication


Featured researches published by Veerle Vanheusden.


Journal of Biological Chemistry | 2003

Enzymatic and structural analysis of inhibitors designed against Mycobacterium tuberculosis thymidylate kinase. New insights into the phosphoryl transfer mechanism.

Ahmed Haouz; Veerle Vanheusden; Hélène Munier-Lehmann; Mattheus Froeyen; Piet Herdewijn; Serge Van Calenbergh; Marc Delarue

The chemical synthesis of new compounds designed as inhibitors of Mycobacterium tuberculosis TMP kinase (TMPK) is reported. The synthesis concerns TMP analogues modified at the 5-position of the thymine ring as well as a novel compound with a six-membered sugar ring. The binding properties of the analogues are compared with the known inhibitor azido-TMP, which is postulated here to work by excluding the TMP-bound Mg2+ ion. The crystallographic structure of the complex of one of the compounds, 5-CH2OH-dUMP, with TMPK has been determined at 2.0 Å. It reveals a major conformation for the hydroxyl group in contact with a water molecule and a minor conformation pointing toward Ser99. Looking for a role for Ser99, we have identified an unusual catalytic triad, or a proton wire, made of strictly conserved residues (including Glu6, Ser99, Arg95, and Asp9) that probably serves to protonate the transferred PO3 group. The crystallographic structure of the commercially available bisubstrate analogueP 1-(adenosine-5′)-P 5-(thymidine-5′)-pentaphosphate bound to TMPK is also reported at 2.45 Å and reveals an alternative binding pocket for the adenine moiety of the molecule compared with what is observed either in the Escherichia coli or in the yeast enzyme structures. This alternative binding pocket opens a way for the design of a new family of specific inhibitors.


Journal of Medicinal Chemistry | 2003

3‘-C-Branched-Chain-Substituted Nucleosides and Nucleotides as Potent Inhibitors of Mycobacterium tuberculosis Thymidine Monophosphate Kinase

Veerle Vanheusden; Hélène Munier-Lehmann; Matheus Froeyen; Laurence Dugué; Arne Heyerick; Denis De Keukeleire; Sylvie Pochet; Roger Busson; Piet Herdewijn; Serge Van Calenbergh


Journal of Medicinal Chemistry | 2004

Discovery of Bicyclic Thymidine Analogues as Selective and High-Affinity Inhibitors of Mycobacterium tuberculosis Thymidine Monophosphate Kinase

Veerle Vanheusden; Hélène Munier-Lehmann; Matheus Froeyen; Roger Busson; Jef Rozenski; Piet Herdewijn; Serge Van Calenbergh


Bioorganic & Medicinal Chemistry Letters | 2002

Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.

Veerle Vanheusden; Hélène Munier-Lehmann; Sylvie Pochet; Piet Herdewijn; Serge Van Calenbergh


Bioorganic & Medicinal Chemistry Letters | 2003

Thymidine and thymidine-5′-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase

Veerle Vanheusden; Philippe Van Rompaey; Hélène Munier-Lehmann; Sylvie Pochet; Piet Herdewijn; Serge Van Calenbergh


Journal of Organic Chemistry | 2004

Synthesis and conformational analysis of 1-[2,4-dideoxy-4-C-hydroxymethyl-alpha-l-lyxopyranosyl]thymine.

Veerle Vanheusden; Roger Busson; Piet Herdewijn; Serge Van Calenbergh


Archive | 2003

Enzymatic and Structural Analysis of Inhibitors Designed against Mycobacterium tuberculosis Thymidylate Kinase

Ahmed Haouz; Veerle Vanheusden; Mattheus Froeyen; Piet Herdewijn; Serge Van Calenbergh; Marc Delarue


European Journal of Organic Chemistry | 2003

Mycobacterium tuberculosis thymidine monophosphate kinase inhibitors: Biological evaluation and conformational analysis of 2 '- and 3 '-modified thymidine analogues

Philippe Van Rompaey; Koen Nauwelaerts; Veerle Vanheusden; Jef Rozenski; Hélène Munier-Lehmann; Piet Herdewijn; Serge Van Calenbergh


Journal of Medicinal Chemistry | 2002

5‘-Deoxy Congeners of 9-(3-Amido-3-deoxy-β-d-xylofuranosyl)-N6-cyclopentyladenine: New Adenosine A1 Receptor Antagonists and Inverse Agonists

Serge Van Calenbergh; Andreas Link; Shelly Fujikawa; Rianne A.F. de Ligt; Veerle Vanheusden; Abolfasl Golisade; Norbert Blaton; Jef Rozenski; A. P. Ijzerman; Piet Herdewijn


Collection of Czechoslovak Chemical Communications | 1999

5'-Deoxy congeners of 9-(3-amido-3-deoxy-β-D-xylofuranosyl)- N 6 -cyclopentyladenine: New adenosine A 1 receptor antagonists

Serge Van Calenbergh; Andreas Link; Shelly Fujikawa; Veerle Vanheusden; Denis De Keukeleire; Adriaan P. IJzerman; Piet Herdewijn

Collaboration


Dive into the Veerle Vanheusden's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Piet Herdewijn

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar

Hélène Munier-Lehmann

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jef Rozenski

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar

Roger Busson

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matheus Froeyen

Rega Institute for Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge